Picture of Anthem Biosciences logo

ANTHEM — Anthem Biosciences Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Anthem Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
R2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,4614,9734,7736,5698,242
Depreciation
Non-Cash Items-91.6-365-370-160-492
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2,619-2,186-3,820-4,597-646
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities3,3293,0601,4022,7068,445
Capital Expenditures-1,576-1,889-2,963-2,656-2,112
Purchase of Fixed Assets
Other Investing Cash Flow Items-479-1,8717491,190-4,905
Sale of Fixed Assets
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-2,055-3,760-2,215-1,466-7,016
Financing Cash Flow Items-23-256-357-97.9-68.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,807640-772-1,356-400
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3,081-60.6-1,585-1211,026